Aripiprazole FDA Link

A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

Also Known As:

Abilify; 7- (4- (4- (2,3- dichlorophenyl)- 1- piperazinyl)butyloxy)- 3,4- dihydro- 2(1H)- quinolinone; Aripiprazol; OPC 14597; OPC-14597

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - Aripiprazole: 2737
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 148
      - Quinolones: 2966
        Aripiprazole: 2737

Ankita A Patel Selected Research

Ankita A Patel Research Topics

Disease

Drug/Important Bio-Agent (IBA)